FI20050814A0 - Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi - Google Patents
Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksiInfo
- Publication number
- FI20050814A0 FI20050814A0 FI20050814A FI20050814A FI20050814A0 FI 20050814 A0 FI20050814 A0 FI 20050814A0 FI 20050814 A FI20050814 A FI 20050814A FI 20050814 A FI20050814 A FI 20050814A FI 20050814 A0 FI20050814 A0 FI 20050814A0
- Authority
- FI
- Finland
- Prior art keywords
- rheumatoid arthritis
- type
- observing
- procedure
- collagen
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Emergency Alarm Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measurement Of Radiation (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20050814A FI20050814A0 (fi) | 2005-08-11 | 2005-08-11 | Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi |
JP2008525592A JP2009505049A (ja) | 2005-08-11 | 2006-08-10 | 関節リウマチにおいて形成される自己抗体を検出するための方法 |
US11/990,227 US20090325884A1 (en) | 2005-08-11 | 2006-08-10 | Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis |
AT06778497T ATE456050T1 (de) | 2005-08-11 | 2006-08-10 | Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern |
EP06778497A EP1946109B1 (en) | 2005-08-11 | 2006-08-10 | Method for detecting autoantibodies formed in rheumatoid arthritis |
PCT/FI2006/000275 WO2007017556A1 (en) | 2005-08-11 | 2006-08-10 | Method for detecting autoantibodies formed in rheumatoid arthritis |
DE602006011934T DE602006011934D1 (de) | 2005-08-11 | 2006-08-10 | Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20050814A FI20050814A0 (fi) | 2005-08-11 | 2005-08-11 | Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20050814A0 true FI20050814A0 (fi) | 2005-08-11 |
Family
ID=34896278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20050814A FI20050814A0 (fi) | 2005-08-11 | 2005-08-11 | Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090325884A1 (fi) |
EP (1) | EP1946109B1 (fi) |
JP (1) | JP2009505049A (fi) |
AT (1) | ATE456050T1 (fi) |
DE (1) | DE602006011934D1 (fi) |
FI (1) | FI20050814A0 (fi) |
WO (1) | WO2007017556A1 (fi) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0708585D0 (en) | 2007-05-03 | 2007-06-13 | Queen Mary & Westfield College | Novel antibody and use in diagnosis and therapy of arthropathies |
EP2058663A1 (en) * | 2007-11-12 | 2009-05-13 | Euro-Diagnostica B.V. | Method for the immobilization of an analyte on a solid support |
EP3112379A1 (en) | 2008-03-21 | 2017-01-04 | Universiteit Hasselt | Biomarkers for rheumatoid arthritis |
EP2325195A1 (en) | 2009-11-23 | 2011-05-25 | Toscana Biomarkers S.r.l. | Viral citrullinated peptides and uses thereof |
EP2402368A1 (en) | 2010-07-02 | 2012-01-04 | Toscana Biomarkers S.r.l. | Histone citrullinated peptides and uses thereof |
US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
CA2807942C (en) * | 2010-08-10 | 2021-07-27 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
EP3412680B1 (en) | 2011-04-05 | 2020-11-04 | Curara AB | Novel peptides that bind to types of mhc class ii and their use in diagnosis and treatment |
EP2527841A1 (en) | 2011-05-25 | 2012-11-28 | Toscana Biomarkers S.r.l. | Methods for the diagnosis of rheumatoid arthritis |
GB201302036D0 (en) * | 2013-02-05 | 2013-03-20 | Queen Mary & Westfield College | Diagnosis |
US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
MX2016010835A (es) | 2014-02-21 | 2017-07-11 | Anokion Sa | Terapeuticos dirigidos a la glucosa. |
US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
EP3638296A1 (en) | 2017-06-16 | 2020-04-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
AU2019225251A1 (en) | 2018-02-26 | 2020-10-15 | AnTolRx, Inc. | Tolerogenic liposomes and methods of use thereof |
CN111868073B (zh) * | 2019-05-31 | 2021-04-30 | 广州市雷德生物科技有限公司 | 一种类风湿关节炎相关的特异性多肽及其应用 |
CN110456074B (zh) * | 2019-08-27 | 2022-06-03 | 广东菲鹏生物有限公司 | 瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒 |
WO2022202876A1 (ja) * | 2021-03-24 | 2022-09-29 | 積水メディカル株式会社 | I型コラーゲンc末端テロペプチドの免疫学的分析方法 |
CN113109574A (zh) * | 2021-04-15 | 2021-07-13 | 北京森美希克玛生物科技有限公司 | 检测抗突变型瓜氨酸化波形蛋白抗体的试剂盒以及检测方法 |
CN113917135A (zh) * | 2021-10-18 | 2022-01-11 | 北京和杰创新生物医学科技有限公司 | 抗角蛋白抗体的免疫球蛋白g的检测方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3513915A1 (de) * | 1985-04-17 | 1986-10-23 | Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin | Immunologischer testkit |
DK104093D0 (da) * | 1993-09-17 | 1993-09-17 | Osteometer A S | Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen |
EP1571450A3 (en) * | 1999-06-17 | 2006-08-16 | Washington Research Foundation | Cartilage resorption assays |
EP1435970A4 (en) * | 2001-10-18 | 2005-05-04 | Ilex Products Inc | METHOD OF TREATING SKIN WITH DIPHOSPHONATE DERIVATIVES |
NL1019540C2 (nl) * | 2001-12-11 | 2003-07-01 | Stichting Tech Wetenschapp | Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit. |
DE60324393D1 (de) * | 2002-02-12 | 2008-12-11 | Univ California | Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte |
AU2003275294A1 (en) * | 2002-09-30 | 2004-04-23 | Shriners Hospital For Children | Products for regulating the degradation of collagen and methodsfor indentifying same |
CA2518187A1 (en) * | 2003-03-07 | 2004-09-16 | London Health Sciences Centre Reseach, Inc. | Peptides associated with hla-dr mhc class ii molecules involved in autoimmune diseases |
ITTO20030246A1 (it) * | 2003-03-31 | 2004-10-01 | Univ Pisa | Nuovi peptidi sintetici citrullinati e loro usi. |
EP1882946B1 (en) * | 2003-12-23 | 2010-02-17 | Roche Diagnostics GmbH | Method of assessing rheumatoid arthritis by measuring anti-CCP and interleukin 6 |
JP2006133177A (ja) * | 2004-11-09 | 2006-05-25 | Institute Of Physical & Chemical Research | 関節リウマチの診断および治療におけるシトルリン化アンチトロンビン3の利用 |
-
2005
- 2005-08-11 FI FI20050814A patent/FI20050814A0/fi unknown
-
2006
- 2006-08-10 US US11/990,227 patent/US20090325884A1/en not_active Abandoned
- 2006-08-10 DE DE602006011934T patent/DE602006011934D1/de active Active
- 2006-08-10 AT AT06778497T patent/ATE456050T1/de not_active IP Right Cessation
- 2006-08-10 WO PCT/FI2006/000275 patent/WO2007017556A1/en active Application Filing
- 2006-08-10 JP JP2008525592A patent/JP2009505049A/ja active Pending
- 2006-08-10 EP EP06778497A patent/EP1946109B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
WO2007017556A1 (en) | 2007-02-15 |
DE602006011934D1 (de) | 2010-03-11 |
ATE456050T1 (de) | 2010-02-15 |
EP1946109A1 (en) | 2008-07-23 |
EP1946109B1 (en) | 2010-01-20 |
US20090325884A1 (en) | 2009-12-31 |
JP2009505049A (ja) | 2009-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20050814A0 (fi) | Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi | |
Wu et al. | Anti-citrullinated protein antibodies in patients with rheumatoid arthritis: biological effects and mechanisms of immunopathogenesis | |
Tabolacci et al. | The role of tissue transglutaminase in cancer cell initiation, survival and progression | |
CY1119743T1 (el) | Στοχοθετημενοι συνδετικοι παραγοντες εναντι β7-η1 | |
CY1116967T1 (el) | Συνθεσεις και μεθοδοι για θεραπευτικη αγωγη και διαγνωση καρκινου | |
NO20043245L (no) | Bindingsproteiner som biosensorer | |
CY1119405T1 (el) | Ενωση για την αναστολη ενζυμων | |
CY1118120T1 (el) | Συνθεσεις βασιζομενες σε πεδιο ινωδονεκτινης τυπου iii, μεθοδοι και χρησεις αυτων | |
CY1117759T1 (el) | Ενα καινουργιο φαρμακευτικο παρασκευασμα για την προ-εκλαμψια | |
EP1855719A4 (en) | NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME | |
Sphyris et al. | Subversion of niche-signalling pathways in colorectal cancer: what makes and breaks the intestinal stem cell | |
MX2007007259A (es) | Inhibidores de homodimerizacion de myd88. | |
BR112012022943A2 (pt) | inibidores de syk de imidazopiridnas | |
NO20043259L (no) | Bindingsproteiner som biosensorer | |
Kwon et al. | Impact of posttranslational modification in pathogenesis of rheumatoid arthritis: focusing on citrullination, carbamylation, and acetylation | |
EA200802184A1 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
CY1114735T1 (el) | Θεραπευτικες συνθεσεις οι οποιες περιεχουν εναν ειδικο ανταγωνιστη του υποδοχεα της ενδοθηλινης και εναν αναστολεα της pde5 | |
CY1122198T1 (el) | Ιατρικο προϊον και θεραπεια | |
CY1112322T1 (el) | Παραγωγα σπειρο(5.5)ενδεκανιου | |
ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis | |
NO20070440L (no) | Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt | |
Paradzik et al. | The landscape of signaling pathways and proteasome inhibitors combinations in multiple myeloma | |
EA201291345A1 (ru) | Цитруллинированные гистоновые пептиды и их применение | |
Huang et al. | Janus-Inspired Core–Shell Structure Hydrogel Programmatically Releases Melatonin for Reconstruction of Postoperative Bone Tumor | |
CY1115255T1 (el) | Χρηση αναστολεων αποακετυλασης ιστονων για την φροντιδα philadelphia-αρνητικων μυελοπολλαπλασιαστικων συνδρομων |